Astuprotimut-R Uses, Dosage, Side Effects and more
Astuprotimut-R is under investigation in clinical trial NCT00257738 (0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck).
| Trade Name | Astuprotimut-R |
| Generic | Astuprotimut-R |
| Astuprotimut-R Other Names | Astuprotimut-R |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
